Paul Lyons

24.0k total citations · 3 hit papers
140 papers, 6.4k citations indexed

About

Paul Lyons is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Paul Lyons has authored 140 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Immunology, 39 papers in Molecular Biology and 39 papers in Genetics. Recurrent topics in Paul Lyons's work include T-cell and B-cell Immunology (23 papers), Diabetes and associated disorders (21 papers) and Immune Cell Function and Interaction (17 papers). Paul Lyons is often cited by papers focused on T-cell and B-cell Immunology (23 papers), Diabetes and associated disorders (21 papers) and Immune Cell Function and Interaction (17 papers). Paul Lyons collaborates with scholars based in United Kingdom, United States and Australia. Paul Lyons's co-authors include Kenneth G. C. Smith, Eoin McKinney, David Jayne, James Lee, Linda S. Wicker, John A. Todd, Laurence B. Peterson, Natasha Hill, Christopher J. Lord and Anthony A. Scalzo and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Paul Lyons

131 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ANCA-associated vasculitis

2020 499 citations A. Richard Kitching, Hans‐Joachim Anders et al. Nature Reviews Disease Primers profile →
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection

2015 481 citations Eoin McKinney, James Lee et al. profile →
Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid

2024 41 citations Benjamin A. Krishna, Eleanor Y. Lim et al. Science Advances profile →

Peers

Countries citing papers authored by Paul Lyons

Since Specialization

Citations

This map shows the geographic impact of Paul Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Lyons more than expected).

Fields of papers citing papers by Paul Lyons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Lyons. The network helps show where Paul Lyons may publish in the future.

Co-authorship network of co-authors of Paul Lyons

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Lyons. A scholar is included among the top collaborators of Paul Lyons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Lyons. Paul Lyons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional “step-up” care for patients with active Crohn’s disease: a cost-effectiveness analysis from the PROFILE trial 2025 ·Journal of Crohn s and Colitis ·Nurulamin M Noor, Neil M Davies, (unknown), Simon Bond, Francis Dowling, Kamal Patel, Paul Lyons, Eoin McKinney, Kenneth G. C. Smith, (unknown), (unknown), Miles Parkes, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid breakdown → 2024 ·Science Advances ·Benjamin A. Krishna, Eleanor Y. Lim, (unknown), Sarah Jackson, Lenette Mactavous, (unknown), Paul Lyons, Rainer Döffinger, John R. Bradley, Kenneth G. C. Smith, John Sinclair, Nicholas J. Matheson, Paul J. Lehner, Nyaradzai Sithole, Mark R. Wills	41
3	sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID 2024 ·iScience ·(unknown), Federica Mescia, Laura Bergamaschi, Erika Kajdácsi, György Sinkovits, László Cervenak, Zoltán Prohászka, Paul Lyons, Erik J. M. Toonen	3
4	Proinflammatory cytokines driving cardiotoxicity in COVID-19 2023 ·Cardiovascular Research ·Maria Colzani, Johannes Bargehr, Federica Mescia, Eleanor C Williams, Vincent Knight-Schrijver, (unknown), Charlotte Summers, Irina Mohorianu, Kenneth G. C. Smith, Paul Lyons, Sanjay Sinha	5
5	Altered B-Cell Expansion and Maturation in Draining Mesenteric Lymph Nodes of Inflamed Gut in Crohn’s Disease 2023 ·Cellular and Molecular Gastroenterology and Hepatology ·(unknown), Prasanti Kotagiri, (unknown), (unknown), (unknown), (unknown), Gavin W. Sewell, (unknown), (unknown), (unknown), Barbara Meßner, (unknown), Arthur Kaser, Paul Lyons, Michael Bergmann, Anton Stift, Rudolf Oehler, Lukas Unger	2
6	Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis 2023 ·International Journal of Molecular Sciences ·Federica Mescia, Shaghayegh Bayati, (unknown), Peter Heeringa, Erik J. M. Toonen, (unknown), (unknown), Andrew J. Rees, Renate Kain, Paul Lyons, Peter Nilsson, Elisa Pin	3
7	Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID 2022 ·EBioMedicine ·Benjamin A. Krishna, Eleanor Y. Lim, (unknown), Paul Lyons, Rainer Döffinger, John R. Bradley, Kenneth G. C. Smith, John Sinclair, Nicholas J. Matheson, Paul J. Lehner, Mark R. Wills, Nyaradzai Sithole	24
8	ANCA-associated vasculitis breakdown → 2020 ·Nature Reviews Disease Primers ·A. Richard Kitching, Hans‐Joachim Anders, Neil Basu, Elisabeth Brouwer, Jennifer Gordon, David Jayne, Joyce Kullman, Paul Lyons, Peter A. Merkel, Caroline O. S. Savage, Ulrich Specks, Renate Kain	499
9	A blood-based prognostic biomarker in IBD 2019 ·Gut ·Daniele Biasci, James Lee, Nurulamin M Noor, (unknown), (unknown), Nina Lewis, Tariq Ahmad, Ailsa Hart, Miles Parkes, Eoin McKinney, Paul Lyons, Kenneth G. C. Smith	127
10	PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial 2018 ·BMJ Open ·Miles Parkes, Nurulamin M Noor, Francis Dowling, (unknown), Simon Bond, Lynne Whitehead, Sara Upponi, (unknown), Andrew Sandham, Paul Lyons, Eoin McKinney, Kenneth G. C. Smith, James Lee	41
11	Monitoring Ireland’s Payments using TARGET2 2017 ·RePEc: Research Papers in Economics ·(unknown), Paul Lyons, (unknown)	1
12	Macroprudential Measures and Irish Mortgage Lending: An Overview of Lending in 2016 2017 ·Economics Letters ·(unknown), Paul Lyons, Yvonne McCarthy, Conor O’Toole	1
13	Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options 2017 ·Journal of Molecular Medicine ·(unknown), Thomas Rose, Shaun Flint, Jens Klotsche, Thomas Häupl, Markus Peck‐Radosavljevic, Taketoshi Yoshida, Chieko Kyogoku, (unknown), Amy M. Becker, Kathryn H. Dao, Andreas Radbruch, Gerd R Burmester, Paul Lyons, Laurie S. Davis, Falk Hiepe, Andreas Grützkau, Robert Biesen	17
14	A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus 2010 ·Proceedings of the National Academy of Sciences ·Lisa Willcocks, Edward J Carr, Heather Niederer, Tim F. Rayner, Thomas N. Williams, Wanling Yang, J. Anthony G. Scott, Britta C. Urban, Norbert Peshu, Timothy J. Vyse, YL Lau, Paul Lyons, Kenneth G. C. Smith	141
15	Efficient inhibition of miR-155 function in vivo by peptide nucleic acids 2010 ·Nucleic Acids Research ·Martin M. Fabani, Cei Abreu‐Goodger, Donna Williams, Paul Lyons, Adrián Gabriel Torres, Kenneth G. C. Smith, Anton J. Enright, Michael J. Gait, Elena Vigorito	175
16	Distinct cell-specific control of autoimmunity and infection by FcγRIIb 2008 ·The Journal of Experimental Medicine ·Rebecca J. Brownlie, Kate E. Lawlor, Heather Niederer, Antony J. Cutler, Zou Xiang, Menna R. Clatworthy, R. Andrés Floto, David R. Greaves, Paul Lyons, Kenneth G. C. Smith	129
17	Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake 2008 ·The Journal of Experimental Medicine ·Lisa Willcocks, Paul Lyons, Menna R. Clatworthy, James Robinson, Wanling Yang, Stephen A. Newland, Vincent Plagnol, Naomi McGovern, Alison M. Condliffe, Edwin R. Chilvers, Dwomoa Adu, Elaine C. Jolly, Richard A. Watts, YL Lau, Ann W Morgan, Gerard B. Nash, Kenneth G. C. Smith	183
18	Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification 2007 ·BMC Genomics ·Paul Lyons, Maria Koukoulaki, (unknown), Karen Doggett, Hayley Woffendin, Afzal Chaudhry, Kenneth G. C. Smith	86
19	Fine Mapping, Gene Content, Comparative Sequencing, and Expression Analyses Support Ctla4 and Nramp1 as Candidates for Idd5.1 and Idd5.2 in the Nonobese Diabetic Mouse 2004 ·The Journal of Immunology ·Linda S. Wicker, Giselle Chamberlain, Kara Hunter, Dan Rainbow, Sarah Howlett, (unknown), Jan Clark, Andrea González-Muñoz, Anne Marie Cumiskey, Raymond Rosa, Joanna M. M. Howson, Luc J Smink, (unknown), Paul Lyons, Simon G. Gregory, Jane Rogers, John A. Todd, Laurence B. Peterson	91
20	Mapping and Transcriptional Analysis of the Murine Cytomegalovirus Homologue of the Human Cytomegalovirus UL103 Open Reading Frame 1994 ·Virology ·Paul Lyons, Peter B. Dallas, (unknown), Geoffrey Shellam, Anthony A. Scalzo	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact